Table 1: Demographic and Clinical Characteristics - Obj_2_AF for onsnoncoviddeath
	Total	DOAC use	warfarin use

1	  371,551 (100.0)	  279,456 (100.0)	   92,095 (100.0)

Grouped age
1	      621 (0.2)	      510 (0.2)	      111 (0.1)
2	    2,666 (0.7)	    2,306 (0.8)	      360 (0.4)
3	   14,963 (4.0)	   12,727 (4.6)	    2,236 (2.4)
4	   52,018 (14.0)	   42,229 (15.1)	    9,789 (10.6)
5	  132,505 (35.7)	   98,545 (35.3)	   33,960 (36.9)
6	  168,778 (45.4)	  123,139 (44.1)	   45,639 (49.6)

Male
0	  158,706 (42.7)	  122,376 (43.8)	   36,330 (39.4)
1	  212,845 (57.3)	  157,080 (56.2)	   55,765 (60.6)

Grouped BMI
1	    6,482 (1.7)	    5,323 (1.9)	    1,159 (1.3)
2	   93,761 (25.2)	   72,001 (25.8)	   21,760 (23.6)
3	  126,246 (34.0)	   94,345 (33.8)	   31,901 (34.6)
4	   77,111 (20.8)	   57,482 (20.6)	   19,629 (21.3)
5	   32,056 (8.6)	   23,958 (8.6)	    8,098 (8.8)
6	   17,044 (4.6)	   12,511 (4.5)	    4,533 (4.9)
.	   18,851 (5.1)	   13,836 (5.0)	    5,015 (5.4)

Smoking status
1	  134,043 (36.1)	  101,140 (36.2)	   32,903 (35.7)
2	  215,559 (58.0)	  161,227 (57.7)	   54,332 (59.0)
3	   21,578 (5.8)	   16,755 (6.0)	    4,823 (5.2)
.	      371 (0.1)	      334 (0.1)	       37 (0.0)

Ethnicity
1	  265,375 (71.4)	  199,186 (71.3)	   66,189 (71.9)
2	      655 (0.2)	      541 (0.2)	      114 (0.1)
3	    4,629 (1.2)	    3,877 (1.4)	      752 (0.8)
4	    1,536 (0.4)	    1,280 (0.5)	      256 (0.3)
5	    1,370 (0.4)	    1,091 (0.4)	      279 (0.3)
.	   97,986 (26.4)	   73,481 (26.3)	   24,505 (26.6)

Index of Multiple Deprivation (IMD)
1	   75,033 (20.2)	   57,394 (20.5)	   17,639 (19.2)
2	   74,004 (19.9)	   55,905 (20.0)	   18,099 (19.7)
3	   75,725 (20.4)	   56,424 (20.2)	   19,301 (21.0)
4	   73,039 (19.7)	   54,472 (19.5)	   18,567 (20.2)
5	   73,750 (19.8)	   55,261 (19.8)	   18,489 (20.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  255,442 (68.8)	  195,128 (69.8)	   60,314 (65.5)
2	   84,734 (22.8)	   60,914 (21.8)	   23,820 (25.9)
3	   30,260 (8.1)	   22,591 (8.1)	    7,669 (8.3)
4	    1,115 (0.3)	      823 (0.3)	      292 (0.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diagnosed hypertension
1	  261,029 (70.3)	  194,327 (69.5)	   66,702 (72.4)
Heart Failure
1	   98,003 (26.4)	   71,156 (25.5)	   26,847 (29.2)
Diabetes
1	  116,109 (31.2)	   84,328 (30.2)	   31,781 (34.5)
COPD
1	   47,296 (12.7)	   36,060 (12.9)	   11,236 (12.2)
Other Respiratory Diseases
1	   21,111 (5.7)	   16,398 (5.9)	    4,713 (5.1)
Cancer
1	   65,518 (17.6)	   49,318 (17.6)	   16,200 (17.6)
Immunosuppressed (combination algorithm)
1	    2,212 (0.6)	    1,684 (0.6)	      528 (0.6)
Chronic kidney disease
1	  129,926 (35.0)	   95,384 (34.1)	   34,542 (37.5)
Flu vaccine
1	  297,806 (80.2)	  219,441 (78.5)	   78,365 (85.1)
Recent Oestrogen
1	    2,004 (0.5)	    1,647 (0.6)	      357 (0.4)
Recent antiplatelet
1	   23,016 (6.2)	   18,920 (6.8)	    4,096 (4.4)
Myocardial infarction
1	   42,164 (11.3)	   31,767 (11.4)	   10,397 (11.3)
Peripheral arterial disease
1	   19,297 (5.2)	   14,212 (5.1)	    5,085 (5.5)
Stroke/Transient ischaemic attack
1	   78,464 (21.1)	   60,039 (21.5)	   18,425 (20.0)
Venous thromboembolism
1	   28,043 (7.5)	   19,858 (7.1)	    8,185 (8.9)


GP consultation count
Median (IQR)	11 (6-20)	10 (6-17)	17 (9-27)
Min, Max	0, 432	0, 432	0, 307
Age (years)
Median (IQR)	78 (72-85)	78 (71-84)	79 (73-85)
Min, Max	18, 107	18, 107	24, 105
A&E attendance count
Median (IQR)	0 (0-1)	0 (0-1)	0 (0-1)
Min, Max	0, 69	0, 69	0, 45
